Results 261 to 270 of about 231,281 (308)

Active surveillance for the safety and effectiveness of health products for COVID-19: a scoping review. [PDF]

Front Pharmacol
Yousef S, Bai Z, Kelly SE, Skidmore B, Wells G.   +4 more
europepmc   +1 more source

Prevalence of transthyretin cardiac amyloidosis in undifferentiated heart failure with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 1176-1182, April 2025.
Abstract Aims Transthyretin amyloid cardiomyopathy (ATTR‐CM) is an increasinglyrecognized cause of heart failure with preserved ejection fraction (HFpEF), which may be diagnosed non‐invasively using 99mTc 3,3‐diphosphono‐1,2‐propanodicarboxylic acid (DPD) scintigraphy‐based diagnostic criteria.
L. Healy, G. Giblin, A. Gray, N. Starr, L. Murphy, D. O'Sullivan, E. Kavanagh, C. Howley, C. Tracey, E. Morrin, A. McDaid, A. Clarke, J.O. O'Neill, E. Joyce, M. O'Connell, N. G. Mahon   +15 more
wiley   +1 more source

Repurposed Medicines for Viruses With Epidemic or Pandemic Potential: A Horizon Scan. [PDF]

Pharmacol Res Perspect
Akinbolade S, Potter R, Inskip A, Nesworthy J, Brock K, Norman G.   +5 more
europepmc   +1 more source

eGFR slope as predictor of mortality in heart failure patients

ESC Heart Failure, Volume 12, Issue 2, Page 1217-1226, April 2025.
Abstract Aims Heart failure (HF) leads to an imbalance between heart and kidney function, resulting in poor outcomes. However, the prognostic significance of the estimated glomerular filtration rate (eGFR) trajectory in HF patients remains unclear. We analysed electronic health records (EHRs) of real‐world HF patients, assessing eGFR trajectories and ...
Sofie Verstreken, Monika Beles, Clara L. Oeste, Ana Moya, Imke Masuy, Riet Dierckx, Ward Heggermont, Jeroen Dauw, Dries Hens, Jozef Bartunek, Marc Vanderheyden   +10 more
wiley   +1 more source

Association of Body Mass Index with SARS-CoV-2 Infection in Inflammatory Arthritis Patients Receiving Biologic Therapy: Singapore National Biologics Register Findings. [PDF]

Int J Rheum Dis
Dhanasekaran P, Yeo SI, Ng YX, Lim R, Wong S, Angkodjojo S, Khor AYK, Koh LW, Lahiri M, Ma M.   +9 more
europepmc   +1 more source

Bone Marrow Mesenchymal Stem Cell Extracellular Vesicle Treatment of Respiratory Failure from COVID-19: Endpoint Analysis of Expanded Access Safety Trial. [PDF]

Stem Cell Rev Rep
Sengupta V, Qian S, Ransom JT, Suzuki S, Park DJ, Melson TI, Williams BP, Walsh JJ, Awili M, Mann JM, Moseley TA.   +10 more
europepmc   +1 more source

Epidemiology of hospitalized heart failure in France based on national data over 10 years, 2012–2022

ESC Heart Failure, Volume 12, Issue 2, Page 1283-1294, April 2025.
Abstract Aims We aim to describe the incidence of HF hospitalization in France in the post‐pandemic era, the prevalence of HF cases and patients' characteristics, management and outcomes while focusing on sex, age and socio‐economic differences and to analyse time‐trends between 2012 and 2022.
Valérie Olié, Richard Isnard, Françoise Pousset, Clémence Grave, Jacques Blacher, Amélie Gabet   +5 more
wiley   +1 more source

Interventions for treating COVID-19 in people with chronic kidney disease. [PDF]

Cochrane Database Syst Rev
Abd ElHafeez S, Natale P, Hosseini K, Colaneri M, Gallieni M, Strippoli GF, supported by Cochrane Kidney and Transplant Review Group.   +6 more
europepmc   +1 more source

Conspiracy Theory Endorsement Profiles: A Cluster Validation Study

European Journal of Social Psychology, EarlyView.
ABSTRACT A substantial body of research has investigated the determinants of conspiratorial beliefs, yet little is known about different conspiracy theory endorsement profiles. The present study used cluster analysis on a set of 52 conspiratorial statements tapping into six conspiracy theory types to identify and validate conspiracy theory endorsement ...
Otto Mäki, Eetu Marttila, Tuomo Häikiö, Daria Pritup, Kaisa Elovaara, Pasi Kivioja, Johanna K. Kaakinen   +6 more
wiley   +1 more source

Risk assessment for cardiovascular adverse drug events in the ICU: Case study on COVID-19 patients. [PDF]

PLoS One
Freitas NL, Oliveira RD, Santos AKDS, Cunha-Filho M, Medeiros-Souza P.   +4 more
europepmc   +1 more source